Prevention or Early Cure of Type 1 Diabetes by Intranasal Administration of Gliadin in NOD Mice
Open Access
- 1 January 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (4) , e94530
Abstract
Induction of long-term tolerance to β-cell autoantigens has been investigated both in animal models and in human type 1 diabetes (T1D) in order to prevent the disease. As regards external compounds, the dietary plant protein fraction has been associated with high penetrance of the disease, whereas gluten-free diets prevent T1D in animal models. Herewith we investigated whether intranasal (i.n.) administration of gliadin or gluten may arrest the diabetogenic process. I.n. administration of gliadin to 4-week-old NOD mice significantly reduced the diabetes incidence. Similarly, the insulitis was lowered. Intranasal gliadin also rescued a fraction of prediabetic 13-week-old NOD mice from progressing to clinical onset of diabetes compared to OVA-treated controls. Vaccination with i.n. gliadin led to an induction of CD4+Foxp3+ T cells and even more significant induction of γδ T cells in mucosal, but not in non-mucosal lymphoid compartments. This prevention strategy was characterized by an increased proportion of IL-10 and a decreased proportion of IL-2, IL-4 and IFN-γ-positive CD4+Foxp3+ T cells, and IFN-γ-positive γδ T cells, preferentially in mucosal lymphoid organs. In conclusion, i.n. vaccination with gliadin, an environmental antigen with possible etiological influence in T1D, may represent a novel, safer strategy for prevention or even early cure of T1D.Keywords
This publication has 52 references indexed in Scilit:
- Impact of Dietary Gluten on Regulatory T Cells and Th17 Cells in BALB/c MicePLOS ONE, 2012
- Sensitization to Gliadin Induces Moderate Enteropathy and Insulitis in Nonobese Diabetic-DQ8 MiceThe Journal of Immunology, 2011
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialThe Lancet, 2011
- Virtual Optimization of Nasal Insulin Therapy Predicts Immunization Frequency to Be Crucial for Diabetes ProtectionDiabetes, 2010
- Gamma delta T cell receptors confer autonomous responsiveness to the insulin-peptide B:9-23Journal of Autoimmunity, 2010
- Incidence of Autoimmune Diseases in Celiac Disease: Protective Effect of the Gluten-Free DietClinical Gastroenterology and Hepatology, 2008
- Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing TregsJournal of Clinical Investigation, 2006
- Mucosal Tolerance to Prevent Type 1 Diabetes: Can the Outcome Be Improved in Humans?The Review of Diabetic Studies, 2004
- Diabetogenic T cells are primed both in pancreatic and gut‐associated lymph nodes in NOD miceEuropean Journal of Immunology, 2003
- Defining criteria for autoimmune diseases (Witebsky's postulates revisited)Immunology Today, 1993